Form 4 Tracker
Adam Scott Levy

CFO and Secretary · 1 filing · Latest: Feb 19, 2026

Mineralys Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MLYS
Levy Adam Scott—Jan 12, 2026
Proposed Sale
$32.1410,758$345.7K—
MLYS
Levy Adam Scott—Nov 11, 2025
Proposed Sale
$44.88119,524$5.4M—
MLYS
Levy Adam Scott—Oct 13, 2025
Proposed Sale
$42.0110,758$452.0K—
MLYS
Levy Adam Scott—Jul 30, 2025
Proposed Sale
$14.7659,925$884.4K—
MLYS
Levy Adam Scott—Jul 29, 2025
Proposed Sale
$14.00807$11.3K—
MLYS
Levy Adam Scott—Jul 28, 2025
Proposed Sale
$14.0412,946$181.8K—
MLYS
Levy Adam Scott—Jul 11, 2025
Proposed Sale
$14.4510,758$155.5K—
MLYS
Levy Adam Scott—Apr 11, 2025
Proposed Sale
$12.0610,757$129.7K—
MLYS
Levy Adam Scott—Jan 13, 2025
Proposed Sale
$9.1010,757$97.9K—
MLYS
Levy Adam Scott—Oct 11, 2024
Proposed Sale
$13.5710,757$146.0K—